SPECIAL NOTICE
A -- The United States Army Medical Research Acquisitions Activity on behalf of the U.S. Army Medical Material Development Activity, is issuing a Notice of Intent to Award a Sole Source contract.
- Notice Date
- 3/23/2015
- Notice Type
- Special Notice
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014
- ZIP Code
- 21702-5014
- Solicitation Number
- W81XWH15JWMRP
- Archive Date
- 3/22/2016
- Point of Contact
- Kelly R. Green, 301-619-1346
- E-Mail Address
-
US Army Medical Research Acquisition Activity
(kelly.r.green.civ@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- This is not a request for proposals. This notice does not represent a commitment by the government to pay for cost incurred in preparation and submission of data in response to this announcement. Methodist Hospital, in conjunction with the Christopher and Dana Reeve Foundation proposes to implement a Phase 2/3 randomized, double blind, controlled clinical trial of the neuroprotective drug riluzole for acute SCI. This notice of intent is for information purposes only. The action will be awarded without further notice.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/USAMRAA/DAMD17/W81XWH15JWMRP/listing.html)
- Record
- SN03676436-W 20150325/150323235947-c4a906593eb61dbcbf90e083be3fe790 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |